| 英文名稱 | Diosgenin |
|---|---|
| 中文名稱 | 薯蕷皂苷元/薯蕷皂素/薯蕷皂苷/異螺環(huán)-5-烯-3Beta-醇/(25R)-螺甾-5-烯-3β-醇/2H5]-薯蕷皂苷元/(3β,25R)-螺甾-5-烯-3-醇/薯芋皂苷配基/薯芋皂素/薯蕷皂甙元/地奧配質(zhì)/黃姜皂素/(2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氫螺[萘并[2',1':4,5]茚并[2,1,1-b]呋喃-10,2'吡喃]-4-醇 |
| CAS號(hào) | 512-04-9 |
| 分子式 | C27H42O3 |
| 分子量 | 414.62 |
| 外觀 | 白色粉末 |
| 熔點(diǎn) | 205.5 °C |
| 沸點(diǎn) | 527.1±50.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 15.02±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000526
中文名稱：薯蕷皂苷元
中文別名：薯蕷皂素；薯蕷皂苷；異螺環(huán)-5-烯-3Beta-醇；(25R)-螺甾-5-烯-3β-醇；2H5]-薯蕷皂苷元；(3β,25R)-螺甾-5-烯-3-醇；薯芋皂苷配基；薯芋皂素；薯蕷皂甙元；地奧配質(zhì)；黃姜皂素；(2'R,4S,5'R,6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氫螺[萘并[2',1':4,5]茚并[2,1,1-b]呋喃-10,2'吡喃]-4-醇
英文名稱：Diosgenin
英文別名：25D-Spirost-5-en-3β-ol (6CI,7CI);Spirost-5-en-3β-ol, (25R)- (8CI);(3β,25R)-Spirost-5-en-3-ol;Spiro[8H-naphth[2',1':4,5]indeno[2,1-b]furan-8,2'-[2H]pyran], spirost-5-en-3-ol deriv.;(25R)-Spirost-5-en-3β-ol;25α-Spirost-5-en-3β-ol;Diosgenin;NSC 33396;Nitogenin;
分子式：C27H42O3
分子量：414.62
CAS號(hào)：512-04-9
純度：HPLC≥98%
熔點(diǎn)：205.5 °C
沸點(diǎn)：527.1±50.0 °C | Condition: Press: 760 Torr
密度：1.13±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：15.02±0.70 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Efficient enzyme-catalyzed production of diosgenin: inspired by the biotransformation mechanisms of steroid saponins in Talaromyces stollii CLY-6 | ||
| 來(lái)源：SCI：GREEN CHEMISTRY | 作者：Leiyu Cheng | 備注：影響因子：10.182 |
| 引用描述 | ||
Dried tubers of Dioscorea zingiberensis C.H. Wright (DZW, Fig. 1b; powder form, P-DZW, Fig. 1c) and crude extract of DZW (E-DZW, Fig. 1d) were supplied by Zunyi City Bei Yuan Chemical Co., Ltd (China). The standard materials of diosgenin, zingiberensis newsaponin (S1), deltonin (S2), prosapogenin A (S3), trillin (S6), polyphyllin I, and dioscin were purchased from Sichuan Weikeqi Biotechnology Co., Ltd (China). Diosgenin triglucoside (S4) and diosgenin diglucoside (S5) were purified from E-DZW. All other chemicals and reagents were of analytical grade and purchased from Beijing Chemical Co., Ltd (China). | ||
| Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction | ||
| 來(lái)源：SCI：PHARMACOLOGICAL RESEARCH | 作者：Min Xu | 備注：影響因子：4.816 |
| 引用描述 | ||
hecogenin (1), diosgenin (2), ruscogenin (3), gitogenin (4), tigogenin (5), solasodine (6), (24S,25S)-3β, 24-di-hydroxy-5α-spirostan (7), dracaenol C (8), 25(27)-dehydroruscogenin (9), (1β, 3β, 14α, 15α, 20R, 22S, 25R)-spirost-5-ene-tetrol (10), peimine (11), peiminine (12), peimisine (13), isoverticine (14), trillin (15), polyphyllin VI (16), polyphyllin VII (17), pallidifloside D (18), prosapogenin A (19), spongipregnoloside A (20), dioscin(21), solasonine (22), solamargine (23), gracillin (24), polyphyllin I(25), timosaponin BII (26), timosaponinA-III(27), ophiopogonin D (28), protobioside (29), (22S,25S)-26-O-β-d-glucopyranosyl-22,25-epoxyfurost-5-en-3β,26-diol-3-O-α-l-rha-mnopyranosyl(1 → 2)-β-d-gluc (30), pallidifloside E (31), parispseudoside (32), methylprotodioscin (33), protodioscin (34), pseudoprotodioscin (35), YS-IX (36), pallidifloside A (37), pallidifloside H (38), digoxin (39), bisdigoxigenin (40), 7β, 14α, 21-tri-hydroxy-diosgenin (41), 12β,14α,21-tri-hydroxy-diosgenin (42), and 11β,14α-di-hydroxyldiosgenin (43) were purchase from Sichuan weikeqi biotechnology company (Sichuan province, China). Pooled human liver microsomes (HLMs, 20 mg/mL) and pooled human primary hepatocytes were purchased from Rild Research Institute for LiverDiseases (Shanghai, China). | ||
